What the superinvestors bought and sold in 2025 Q1
2025 Q1
136 of 137 filedThe quarter at a glance
78 of 136 managers were net sellers. Setting price aside, they took $9.5B out, led by Financials (−$10.4B), while adding to Energy (+$2.6B). FLUT was the most widely bought stock (13 bought, 2 sold); GOOGL / GOOG the most widely sold (28 sold, 10 bought).
Net buyers
52 of 136 managers
78 sold more than they bought · 6 about even
Net bought
−$9.5B
Price moves taken out; prices alone moved the book −$27B.
Positions opened
630
729 closed out. IPOs, spin-offs and mergers left out.
Combined book, last quarter
−2.0%
SPY −4.6%,
2.6 pts ahead.
Price only.
Most bought and sold
Ranked by net dollars bought or sold, with price moves taken out. Open a stock to see who.
Most bought
-
1 AAPL Apple Inc. 5 bought · 13 sold +$5.9B
Bought by
- Duan Yongping - H&H International Investment opened 63.3% of book
- Estuary Capital Management opened 9.3% of book
- Robert Olstein - Olstein Capital Management added 0.51% → 0.94%
- Ron Baron - Bamco Inc. (Baron Capital) added 0.20% → 0.21%
- Dodge & Cox added <0.01% → <0.01%
Sold by
- Jensen Investment Management cut 7.5% → 6.9%
- Lewis Sanders - Sanders Capital cut 6.4% → 4.8%
- Polen Capital Management cut 4.2% → 1.9%
- Li Lu - Himalaya Capital Management cut 2.9% → 1.1%
- Glen Kacher - Light Street Capital Management cut 2.4% → 0.39%
- Alex Sacerdote - Whale Rock Capital Management closed was 1.7%
- Davidson Kempner Capital Management closed was 0.23%
- Francois Rochon - Giverny Capital cut 0.16% → 0.08%
and 5 more
-
2 PSX Phillips 66 4 bought · 0 sold +$2.1B
Bought by
- Paul Singer - Elliott Investment Management added 0.53% → 12.8%
- Bill Nygren / Oakmark - Harris Associates L P added 1.8% → 2.9%
- Murphy Pohlad - Murphy Pohlad Asset Management opened 0.09% of book
- Mairs & Power added <0.01% → 0.01%
Sold by
No manager sold.
-
3 UBER Uber Technologies Inc. 6 bought · 7 sold +$1.8B
Bought by
- Bill Ackman - Pershing Square opened 18.5% of book
- Thomas Russo - Gardner Russo & Quinn added 2.8% → 3.6%
- David Tepper - Appaloosa added 1.4% → 2.8%
- William Von Mueffling - Cantillon Capital Management added 1.5% → 2.5%
- Thomas Gayner - Markel Group added 0.06% → 0.08%
- Steven Check - Check Capital Management added <0.01% → 0.01%
Sold by
- Ram Parameswaran - Octahedron Capital Management cut 13.0% → 11.7%
- Grant Wonders - Voyager Global Management cut 6.3% → 1.6%
- Glenview Capital Management cut 2.1% → 0.79%
- George Soros - Soros Fund Management cut 0.82% → 0.69%
- Chase Coleman - Tiger Global Management cut 0.59% → 0.04%
- Philippe Laffont - Coatue Management closed was 0.59%
- Lee Ainslie - Maverick Capital cut 0.05% → <0.01%
-
4 MSFT Microsoft Corp. 19 bought · 18 sold +$1.5B
Bought by
- Eric Mandelblatt - Soroban Capital Partners added 19.4% → 21.8%
- Triple Frond Partners added 15.2% → 20.4%
- Altarock Partners added 16.1% → 19.5%
- Grant Wonders - Voyager Global Management added 10.9% → 15.2%
- Chris Hohn - Tci Fund Management added 13.9% → 15.0%
- Chris James - Meritage Group opened 14.3% of book
- Vulcan Value Partners added 8.4% → 9.8%
- Chase Coleman - Tiger Global Management added 8.5% → 8.8%
and 11 more
Sold by
- Terry Smith - Fundsmith cut 11.1% → 9.2%
- John Armitage - Egerton Capital (UK) cut 8.6% → 5.8%
- Jensen Investment Management cut 7.8% → 7.4%
- Nehal Chopra - Ratan Capital Management cut 7.6% → 5.8%
- Polen Capital Management cut 7.3% → 7.0%
- David Tepper - Appaloosa cut 6.3% → 2.3%
- Philippe Laffont - Coatue Management cut 5.0% → 5.4%
- Lee Ainslie - Maverick Capital cut 4.7% → 2.8%
and 10 more
-
5 FLUT Flutter Entmt PLC 13 bought · 2 sold +$1.3B
Bought by
- Ako Capital opened 7.4% of book
- John Armitage - Egerton Capital (UK) added 5.6% → 5.6%
- Stephen Mandel - Lone Pine Capital added 3.7% → 4.2%
- Dan Loeb - Third Point added 3.0% → 3.3%
- Senator Investment Group added 1.6% → 3.0%
- Stanley Druckenmiller - Duquesne Family Office added 0.13% → 2.7%
- Brad Gerstner - Altimeter Capital Management added 1.8% → 2.5%
- Ben Jacobs - Anomaly Capital Management opened 1.9% of book
and 5 more
Sold by
- Tom Bancroft - Makaira Partners cut 8.7% → 7.9%
- Ryan Packard - Hiddenite Capital Partners closed was 1.5%
-
6 OXY Occidental Pete Corp. 4 bought · 2 sold +$1.2B
Bought by
- Duan Yongping - H&H International Investment opened 5.7% of book
- Dodge & Cox added 2.0% → 2.3%
- Francis Chou - Chou Associates Management opened 1.8% of book
- Bruce Berkowitz - Fairholme Capital Management added 0.04% → 0.22%
Sold by
- Rule One Partners cut 6.2% → 5.3%
- Muhlenkamp & Co. closed was 3.6%
-
7 STZ Constellation Brands Inc. 4 bought · 2 sold +$1.2B
Bought by
- Hillman Capital Management added 0.10% → 2.0%
- Warren Buffett - Berkshire Hathaway added 0.47% → 0.85%
- Bill Nygren / Oakmark - Harris Associates L P opened 0.53% of book
- Kentucky Trust Co. - Kentucky Trust added 0.14% → 0.15%
Sold by
- Dan Sundheim - D1 Capital Partners closed was 5.6%
- Robert Karr - Joho Capital closed was 0.38%
-
8 FTV Fortive Corp. 1 bought · 0 sold +$1B
Bought by
- Dodge & Cox added 0.34% → 0.91%
Sold by
No manager sold.
-
9 PDD Pdd Holdings Inc. 5 bought · 8 sold +$898M
Bought by
- Norbert Lou - Punch Card Management added 4.0% → 16.8%
- Duan Yongping - H&H International Investment opened 7.6% of book
- Chase Coleman - Tiger Global Management added 0.96% → 2.0%
- Lewis Sanders - Sanders Capital added 0.73% → 1.2%
- Ron Baron - Bamco Inc. (Baron Capital) added 0.01% → 0.02%
Sold by
- Marc Stad - Dragoneer Investment Group cut 9.4% → 11.4%
- David Tepper - Appaloosa cut 8.0% → 6.2%
- Robert Vinall - Rv Capital AG cut 7.2% → 8.8%
- Alex Sacerdote - Whale Rock Capital Management cut 1.6% → 0.41%
- Sarah Ketterer - Causeway Capital Management cut 0.99% → 0.26%
- Howard Marks - Oaktree Capital Management closed was 0.48%
- Nehal Chopra - Ratan Capital Management closed was 0.26%
- Philippe Laffont - Coatue Management closed was 0.06%
-
10 BDX Becton Dickinson & Co. 4 bought · 4 sold +$893M
Bought by
- Starboard Value opened 7.3% of book
- First Eagle Investment Management added 2.2% → 2.6%
- Dan Sundheim - D1 Capital Partners opened 2.4% of book
- Bill Nygren / Oakmark - Harris Associates L P added 0.27% → 0.50%
Sold by
- Hillman Capital Management cut 2.1% → 1.9%
- David Katz - Matrix Asset Advisors closed was 0.12%
- Jensen Investment Management cut 0.03% → 0.03%
- Mairs & Power cut 0.02% → 0.02%
Not counted as buying: 173 IPOs, spin-offs and new listings.
Most sold
-
1 GOOGL / GOOG Alphabet 10 bought · 28 sold −$3.2B
Sold by
- Li Lu - Himalaya Capital Management cut 39.1% → 35.1%
- Andrew Steginsky - Steginsky Capital cut 27.1% → 22.5%
- Triple Frond Partners cut 19.9% → 13.7%
- Eric Mandelblatt - Soroban Capital Partners cut 17.4% → 12.1%
- Bill Ackman - Pershing Square cut 17.4% → 14.0%
- First Pacific Advisors cut 12.2% → 10.3%
- Thomas Russo - Gardner Russo & Quinn cut 12.2% → 9.0%
- Chris Hohn - Tci Fund Management cut 10.1% → 6.4%
and 20 more
Bought by
- Grant Wonders - Voyager Global Management added 20.2% → 20.0%
- Ram Parameswaran - Octahedron Capital Management added 9.9% → 10.1%
- Seth Klarman - Baupost Group added 7.9% → 9.3%
- Alex Sacerdote - Whale Rock Capital Management added 3.2% → 4.7%
- David Tepper - Appaloosa added 5.5% → 3.7%
- John Armitage - Egerton Capital (UK) added 3.3% → 3.0%
- Sarah Ketterer - Causeway Capital Management added 2.6% → 2.3%
- Duan Yongping - H&H International Investment opened 1.4% of book
and 2 more
-
2 WFC Wells Fargo & Co. 1 bought · 11 sold −$1.7B
Sold by
- First Pacific Advisors cut 3.8% → 3.0%
- Harry Burn - Sound Shore Management cut 3.6% → 3.1%
- Richard Pzena - Pzena Investment Management cut 3.3% → 2.5%
- Dodge & Cox cut 2.9% → 2.4%
- Lee Ainslie - Maverick Capital closed was 2.7%
- Mairs & Power cut 1.6% → 1.6%
- Bill Nygren / Oakmark - Harris Associates L P cut 1.3% → 1.4%
- Don Yacktman - Yacktman Asset Management cut 0.87% → 0.15%
and 3 more
Bought by
- Senator Investment Group opened 1.9% of book
-
3 FISV Fiserv, Inc. 0 bought · 8 sold −$1.7B
Sold by
- Mairs & Power cut 3.7% → 3.9%
- Torray Investment Partners cut 3.7% → 3.9%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.4% → 2.1%
- Senator Investment Group cut 1.5% → 2.1%
- Lewis Sanders - Sanders Capital cut 1.4% → 0.76%
- David Katz - Matrix Asset Advisors closed was 0.70%
- Vulcan Value Partners closed was 0.50%
- Samantha Mclemore - Patient Capital Management closed was 0.10%
Bought by
No manager bought.
-
4 JPM Jpmorgan Chase & Co. 2 bought · 8 sold −$1.5B
Sold by
- Andreas Halvorsen - Viking Global Investors cut 5.8% → 1.7%
- David Katz - Matrix Asset Advisors cut 4.2% → 3.9%
- Thomas Russo - Gardner Russo & Quinn cut 3.4% → 2.9%
- Lewis Sanders - Sanders Capital cut 2.9% → 2.8%
- Torray Investment Partners cut 2.7% → 2.3%
- Richard Pzena - Pzena Investment Management cut 0.50% → 0.27%
- Dodge & Cox cut 0.04% → 0.04%
- Murray Stahl - Horizon Kinetics Asset Management cut 0.01% → <0.01%
Bought by
- George Soros - Soros Fund Management opened 0.84% of book
- Murphy Pohlad - Murphy Pohlad Asset Management added 0.25% → 0.29%
-
5 SPOT Spotify Technology S A 1 bought · 6 sold −$1.4B
Sold by
- Stephen Mandel - Lone Pine Capital closed was 3.0%
- Dan Sundheim - D1 Capital Partners closed was 2.4%
- Andreas Halvorsen - Viking Global Investors cut 2.2% → 0.34%
- Davidson Kempner Capital Management closed was 0.98%
- Cathie Wood - Ark Investment Management cut 0.36% → 0.43%
- Polen Capital Management cut 0.07% → 0.07%
Bought by
- Philippe Laffont - Coatue Management added 1.9% → 3.7%
-
6 PM Philip Morris Intl Inc. 2 bought · 10 sold −$1.3B
Sold by
- Dan Sundheim - D1 Capital Partners cut 7.3% → 3.7%
- Thomas Russo - Gardner Russo & Quinn cut 7.1% → 8.9%
- Stephen Mandel - Lone Pine Capital cut 5.8% → 4.1%
- Terry Smith - Fundsmith cut 5.8% → 7.8%
- Lee Ainslie - Maverick Capital cut 4.6% → 4.3%
- Stanley Druckenmiller - Duquesne Family Office cut 4.4% → 5.7%
- First Eagle Investment Management cut 2.6% → 3.0%
- Andreas Halvorsen - Viking Global Investors cut 2.0% → 1.6%
and 2 more
Bought by
- Philippe Laffont - Coatue Management opened 1.1% of book
- David Katz - Matrix Asset Advisors opened 0.02% of book
-
7 C Citigroup Inc. (C) 3 bought · 7 sold −$1.2B
Sold by
- Kahn Brothers Group cut 13.9% → 12.6%
- First Pacific Advisors cut 6.8% → 6.6%
- Samantha Mclemore - Patient Capital Management cut 5.0% → 5.1%
- Bill Nygren / Oakmark - Harris Associates L P cut 1.5% → 1.8%
- Murphy Pohlad - Murphy Pohlad Asset Management cut 1.5% → 1.4%
- Warren Buffett - Berkshire Hathaway closed was 0.39%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.14%
Bought by
- Harry Burn - Sound Shore Management added 2.9% → 3.4%
- Sarah Ketterer - Causeway Capital Management added 2.0% → 2.0%
- Murray Stahl - Horizon Kinetics Asset Management added <0.01% → <0.01%
-
8 BAC Bank Amer Corp. 5 bought · 10 sold −$1.2B
Sold by
- Li Lu - Himalaya Capital Management cut 29.3% → 26.1%
- Warren Buffett - Berkshire Hathaway cut 11.2% → 10.2%
- Richard Pzena - Pzena Investment Management cut 2.5% → 0.93%
- Bill Nygren / Oakmark - Harris Associates L P cut 1.7% → 2.0%
- Tweedy, Browne Co. cut 1.3% → 1.5%
- Arnold Van Den Berg - Van Den Berg Management I cut 0.90% → 0.77%
- Dodge & Cox cut 0.79% → 0.50%
- Murphy Pohlad - Murphy Pohlad Asset Management cut 0.68% → 0.59%
and 2 more
Bought by
- Dan Sundheim - D1 Capital Partners opened 4.7% of book
- Andreas Halvorsen - Viking Global Investors added 3.5% → 4.3%
- Lewis Sanders - Sanders Capital added 1.4% → 3.0%
- Lee Ainslie - Maverick Capital opened 2.7% of book
- John Rogers - Ariel Investments added 0.08% → 0.41%
-
9 PEP Pepsico Inc. 3 bought · 3 sold −$1.1B
Sold by
- Lindsell Train cut 9.7% → 10.2%
- Terry Smith - Fundsmith closed was 3.7%
- Jensen Investment Management cut 3.5% → 1.8%
Bought by
- David Katz - Matrix Asset Advisors added 1.1% → 2.3%
- Murphy Pohlad - Murphy Pohlad Asset Management added 1.2% → 1.3%
- Robert Olstein - Olstein Capital Management opened 0.58% of book
-
10 ADBE Adobe Inc. 6 bought · 7 sold −$1B
Sold by
- Polen Capital Management cut 3.6% → 3.4%
- Gavin Baker - Atreides Management closed was 3.0%
- Philippe Laffont - Coatue Management cut 2.6% → 1.2%
- Andreas Halvorsen - Viking Global Investors closed was 1.8%
- Ben Jacobs - Anomaly Capital Management closed was 1.6%
- Ron Baron - Bamco Inc. (Baron Capital) closed was 0.02%
- Dodge & Cox cut <0.01% → <0.01%
Bought by
- Robert Karr - Joho Capital added 14.7% → 14.5%
- William Von Mueffling - Cantillon Capital Management added 1.7% → 2.0%
- Wallace Weitz - Weitz Investment Management added 0.92% → 1.7%
- Torray Investment Partners added 0.87% → 1.0%
- Mairs & Power added <0.01% → <0.01%
- Cathie Wood - Ark Investment Management added <0.01% → <0.01%
Not counted as selling: 137 mergers and delistings.
Ranked by dollars, single large books set the order: 1 of these 20 names were traded by one or two managers.
Opened and closed
New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.
Opened by the most managers
-
SGI Somnigroup International Inc. 7 managers avg 1.1% of book · Chris James - Meritage Group, Davidson Kempner Capital Management and 5 more
Opened by
- Chris James - Meritage Group opened 3.1% of book
- Davidson Kempner Capital Management opened 1.3% of book
- Dan Sundheim - D1 Capital Partners opened 1.2% of book
- Seth Klarman - Baupost Group opened 1.2% of book
- Farallon Capital Management opened 0.44% of book
- George Soros - Soros Fund Management opened 0.25% of book
- Senator Investment Group opened 0.02% of book
-
META Meta Platforms Inc. 6 managers avg 3.4% of book · Triple Frond Partners, Estuary Capital Management and 4 more
Opened by
- Triple Frond Partners opened 6.0% of book
- Estuary Capital Management opened 5.3% of book
- Gavin Baker - Atreides Management opened 4.2% of book
- Andreas Halvorsen - Viking Global Investors opened 2.7% of book
- Lee Ainslie - Maverick Capital opened 1.8% of book
- Glenview Capital Management opened 0.64% of book
-
TSM Taiwan Semiconductor Mfg Ltd 6 managers avg 2.6% of book · Ram Parameswaran - Octahedron Capital Management, Robert Karr - Joho Capital and 4 more
Opened by
- Ram Parameswaran - Octahedron Capital Management opened 6.6% of book
- Robert Karr - Joho Capital opened 4.8% of book
- Ryan Packard - Hiddenite Capital Partners opened 2.6% of book
- Mairs & Power opened 0.69% of book
- Duan Yongping - H&H International Investment opened 0.38% of book
- Davidson Kempner Capital Management opened 0.34% of book
-
NVDA Nvidia Corporation 6 managers avg 1.6% of book · Gavin Baker - Atreides Management, Estuary Capital Management and 4 more
Opened by
- Gavin Baker - Atreides Management opened 3.6% of book
- Estuary Capital Management opened 2.5% of book
- Dan Loeb - Third Point opened 2.4% of book
- Duan Yongping - H&H International Investment opened 0.58% of book
- Murphy Pohlad - Murphy Pohlad Asset Management opened 0.27% of book
- George Soros - Soros Fund Management opened 0.09% of book
-
APP Applovin Corp. 6 managers avg 1.3% of book · Nehal Chopra - Ratan Capital Management, Chase Coleman - Tiger Global Management and 4 more
Opened by
- Nehal Chopra - Ratan Capital Management opened 4.5% of book
- Chase Coleman - Tiger Global Management opened 1.7% of book
- Henry Ellenbogen - Durable Capital Partners opened 0.79% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.35% of book
- Davidson Kempner Capital Management opened 0.27% of book
- Christopher Davis - Davis Selected Advisers opened 0.25% of book
-
PRMB Primo Brands Corporation 6 managers avg 0.84% of book · Dan Sundheim - D1 Capital Partners, Lee Ainslie - Maverick Capital and 4 more
Opened by
- Dan Sundheim - D1 Capital Partners opened 2.8% of book
- Lee Ainslie - Maverick Capital opened 1.2% of book
- Andreas Halvorsen - Viking Global Investors opened 0.57% of book
- George Soros - Soros Fund Management opened 0.26% of book
- Davidson Kempner Capital Management opened 0.11% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.02% of book
-
ASML Asml Holding N V 4 managers avg 3.5% of book · Triple Frond Partners, Pat Dorsey - Dorsey Asset Management and 2 more
Opened by
- Triple Frond Partners opened 7.1% of book
- Pat Dorsey - Dorsey Asset Management opened 5.0% of book
- Rule One Partners opened 2.0% of book
- Ben Hoskin - Value Aligned Research Advisors opened <0.01% of book
-
AVGO Broadcom Inc. 4 managers avg 3.5% of book · Situational Awareness, Senator Investment Group and 2 more
Opened by
- Situational Awareness opened 11.7% of book
- Senator Investment Group opened 1.6% of book
- Davidson Kempner Capital Management opened 0.43% of book
- David Tepper - Appaloosa opened 0.26% of book
-
Intra-Cellular Therap… Intra-Cellular Therapies Inc. 4 managers avg 3.0% of book · Davidson Kempner Capital Management, Farallon Capital Management and 2 more
Opened by
- Davidson Kempner Capital Management opened 9.5% of book
- Farallon Capital Management opened 2.2% of book
- George Soros - Soros Fund Management opened 0.23% of book
- John Paulson - Paulson & Co. opened 0.16% of book
-
FLUT Flutter Entmt PLC 4 managers avg 2.5% of book · Ako Capital, Ben Jacobs - Anomaly Capital Management and 2 more
Opened by
- Ako Capital opened 7.4% of book
- Ben Jacobs - Anomaly Capital Management opened 1.9% of book
- Henry Ellenbogen - Durable Capital Partners opened 0.42% of book
- Bill Nygren / Oakmark - Harris Associates L P opened 0.21% of book
Closed out by the most managers
-
GOOGL / GOOG Alphabet 8 managers was avg 1.7% of book · Brad Gerstner - Altimeter Capital Management, Ben Jacobs - Anomaly Capital Management and 6 more
Closed by
- Brad Gerstner - Altimeter Capital Management closed was 3.0%
- Ben Jacobs - Anomaly Capital Management closed was 2.9%
- Andreas Halvorsen - Viking Global Investors closed was 2.2%
- Glen Kacher - Light Street Capital Management closed was 2.1%
- Nehal Chopra - Ratan Capital Management closed was 1.8%
- Senator Investment Group closed was 0.70%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.39%
- John Paulson - Paulson & Co. closed was 0.12%
-
UNH Unitedhealth Group Inc. 6 managers was avg 2.4% of book · Abrams Bison - Abrams Bison Investments, Chris James - Meritage Group and 4 more
Closed by
- Abrams Bison - Abrams Bison Investments closed was 9.4%
- Chris James - Meritage Group closed was 3.6%
- Senator Investment Group closed was 1.1%
- Hillman Capital Management closed was 0.10%
- Francois Rochon - Giverny Capital closed was 0.04%
- Bill Nygren / Oakmark - Harris Associates L P closed was <0.01%
-
CRM Salesforce Inc. 6 managers was avg 1.7% of book · Alex Sacerdote - Whale Rock Capital Management, Glen Kacher - Light Street Capital Management and 4 more
Closed by
- Alex Sacerdote - Whale Rock Capital Management closed was 3.3%
- Glen Kacher - Light Street Capital Management closed was 3.1%
- Brad Gerstner - Altimeter Capital Management closed was 1.6%
- Andreas Halvorsen - Viking Global Investors closed was 1.3%
- Lee Ainslie - Maverick Capital closed was 1.2%
- Corvex Management closed was 0.03%
-
TEAM Atlassian Corporation 6 managers was avg 1.2% of book · Henry Ellenbogen - Durable Capital Partners, Alex Sacerdote - Whale Rock Capital Management and 4 more
Closed by
- Henry Ellenbogen - Durable Capital Partners closed was 3.1%
- Alex Sacerdote - Whale Rock Capital Management closed was 2.0%
- Grant Wonders - Voyager Global Management closed was 0.97%
- Andreas Halvorsen - Viking Global Investors closed was 0.39%
- Chase Coleman - Tiger Global Management closed was 0.37%
- George Soros - Soros Fund Management closed was 0.32%
-
VST Vistra Corp. 5 managers was avg 1.3% of book · Harry Burn - Sound Shore Management, Dan Sundheim - D1 Capital Partners and 3 more
Closed by
- Harry Burn - Sound Shore Management closed was 2.2%
- Dan Sundheim - D1 Capital Partners closed was 1.5%
- Philippe Laffont - Coatue Management closed was 1.4%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.0%
- Andreas Halvorsen - Viking Global Investors closed was 0.27%
-
TSLA Tesla Inc. 5 managers was avg 1.2% of book · Dan Loeb - Third Point, Brad Gerstner - Altimeter Capital Management and 3 more
Closed by
- Dan Loeb - Third Point closed was 2.7%
- Brad Gerstner - Altimeter Capital Management closed was 2.6%
- Lee Ainslie - Maverick Capital closed was 0.64%
- David Katz - Matrix Asset Advisors closed was 0.04%
- Mairs & Power closed was <0.01%
-
AAPL Apple Inc. 5 managers was avg 0.40% of book · Alex Sacerdote - Whale Rock Capital Management, Davidson Kempner Capital Management and 3 more
Closed by
- Alex Sacerdote - Whale Rock Capital Management closed was 1.7%
- Davidson Kempner Capital Management closed was 0.23%
- Arnold Van Den Berg - Van Den Berg Management I closed was 0.06%
- Ruane, Cunniff & Goldfarb closed was <0.01%
- Cathie Wood - Ark Investment Management closed was <0.01%
-
SPY Spdr S&P 500 ETF Tr 5 managers was avg 0.38% of book · Hillman Capital Management, Farallon Capital Management and 3 more
Closed by
- Hillman Capital Management closed was 1.4%
- Farallon Capital Management closed was 0.24%
- Vulcan Value Partners closed was 0.13%
- Samantha Mclemore - Patient Capital Management closed was 0.09%
- First Eagle Investment Management closed was 0.06%
-
WDAY Workday Inc. 4 managers was avg 1.7% of book · Stephen Mandel - Lone Pine Capital, Glen Kacher - Light Street Capital Management and 2 more
Closed by
- Stephen Mandel - Lone Pine Capital closed was 3.0%
- Glen Kacher - Light Street Capital Management closed was 2.1%
- Dan Loeb - Third Point closed was 1.7%
- Ron Baron - Bamco Inc. (Baron Capital) closed was <0.01%
-
FDX Fedex Corp. 4 managers was avg 1.6% of book · Ben Jacobs - Anomaly Capital Management, Harry Burn - Sound Shore Management and 2 more
Closed by
- Ben Jacobs - Anomaly Capital Management closed was 2.5%
- Harry Burn - Sound Shore Management closed was 2.2%
- David Tepper - Appaloosa closed was 1.5%
- Davidson Kempner Capital Management closed was 0.32%
Where the money went
Net bought by sector, with price moves taken out. Pick a sector to see its names.
- Energy 6.1% weight · +0.7 pts +$2.6B 17 bought · 15 sold
- Consumer Discretionary 9.6% weight · −0.3 pts +$2.5B 35 bought · 50 sold
- Health Care 11.0% weight · +1.0 pts +$2.4B 41 bought · 27 sold
- Information Technology 20.5% weight · −1.5 pts +$2B 37 bought · 46 sold
- Materials 2.1% weight · +0.2 pts +$1.5B 17 bought · 11 sold
- Real Estate 2.1% weight · +0.1 pts +$349M 9 bought · 13 sold
- Consumer Staples 6.3% weight · +0.7 pts +$58M 18 bought · 20 sold
- Industrials 10.2% weight · +0.3 pts −$645M 34 bought · 47 sold
- Utilities 1.1% weight · −0.1 pts −$1.1B 13 bought · 12 sold
- Communication Services 8.6% weight · −0.9 pts −$7.9B 23 bought · 55 sold
- Financials 22.6% weight · −0.2 pts −$10.4B 31 bought · 64 sold
Information Technology lost weight (−1.5 pts) even though managers bought $2B of it: weight follows price, not buying. Names without a sector (funds, foreign listings, private shares): −$881M.
Who moved the most
The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.
Biggest new bets
- Duan Yongping - H&H International Investment opened AAPL · Apple Inc. 63.3% of book
- Mohnish Pabrai - Dalal Street opened VAL · Valaris Ltd 23.9% of book
- Bill Ackman - Pershing Square opened UBER · Uber Technologies Inc. 18.5% of book
- Chris James - Meritage Group opened MSFT · Microsoft Corp. 14.3% of book
- Mala Gaonkar - Surgocap Partners opened BSX · Boston Scientific Corp. 13.2% of book
- Glenn Welling - Engaged Capital opened YETI · Yeti Hldgs Inc. 13.0% of book
Most active managers
- Ben Hoskin - Value Aligned Research Advisors 10 opened · 3 closed · +$962M net 275% of book traded
- Situational Awareness 6 opened · 2 closed · +$317M net 188% of book traded
- Dan Sundheim - D1 Capital Partners 17 opened · 12 closed · +$672M net 95% of book traded
- Duan Yongping - H&H International Investment 11 opened · 0 closed · +$12B net 83% of book traded
- Lee Ainslie - Maverick Capital 62 opened · 55 closed · +$350M net 71% of book traded
- Ram Parameswaran - Octahedron Capital Management 3 opened · 5 closed · +$11M net 70% of book traded
What they hold
Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, by dollars, so the biggest books lead it. Highest conviction is the average position among holders, three or more.
Most owned
- 1 GOOGL / GOOG Alphabet 65 managers −7
- 2 MSFT Microsoft Corp. 63 managers −1
- 3 AMZN Amazon Com Inc. 51 managers −1
- 4 META Meta Platforms Inc. 47 managers +4
- 5 TSM Taiwan Semiconductor Mfg Ltd 38 managers +4
- 6 BRK.B / BRK.A Berkshire Hathaway 37 managers +1
- 7 V Visa Inc. 34 managers −1
- 8 NVDA Nvidia Corporation 30 managers +4
- 9 AAPL Apple Inc. 29 managers −3
- 10 UNH Unitedhealth Group Inc. 29 managers −3
Largest
- 1 AAPL Apple Inc. 6.0% held by 29
- 2 MSFT Microsoft Corp. 3.4% held by 63
- 3 AXP American Express Co. 3.1% held by 17
- 4 GOOGL / GOOG Alphabet 2.5% held by 65
- 5 BAC Bank Amer Corp. 2.5% held by 24
- 6 KO Coca Cola Co. 2.2% held by 11
- 7 META Meta Platforms Inc. 2.1% held by 47
- 8 AMZN Amazon Com Inc. 1.9% held by 51
- 9 MCO Moodys Corp. 1.5% held by 18
- 10 V Visa Inc. 1.5% held by 34
Highest conviction
- 1 CVNA Carvana Co. avg 19.2% held by 13
- 2 LOAR Loar Holdings Inc. avg 15.7% held by 3
- 3 TDG Transdigm Group Inc. avg 11.4% held by 6
- 4 BRK.B / BRK.A Berkshire Hathaway avg 10.4% held by 37
- 5 VAL Valaris Ltd avg 9.8% held by 3
- 6 SNX Td Synnex Corporation avg 8.7% held by 6
- 7 VFC Vf Corp. avg 7.7% held by 3
- 8 FICO Fair Isaac Corp. avg 7.6% held by 7
- 9 I3N Chart Inds Inc. avg 7.6% held by 4
- 10 EXEL Exelixis Inc. avg 7.5% held by 3
Did the combined book beat SPY?
Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.
Combined book, 8 quarters
+33.3%
SPY
+37.2%
Difference
−3.9 pts
2024 Q2, the start
+0.0% Combined book
+0.0% SPY
2024 Q3, since 2024 Q2
+6.9% Combined book
+5.4% SPY
That quarter: book +6.9%, SPY +5.4%
2024 Q4, since 2024 Q2
+8.1% Combined book
+7.7% SPY
That quarter: book +1.1%, SPY +2.1%
2025 Q1, since 2024 Q2
+6.0% Combined book
+2.8% SPY
That quarter: book −2.0%, SPY −4.6%
2025 Q2, since 2024 Q2
+14.5% Combined book
+13.5% SPY
That quarter: book +8.0%, SPY +10.5%
2025 Q3, since 2024 Q2
+21.7% Combined book
+22.4% SPY
That quarter: book +6.3%, SPY +7.8%
2025 Q4, since 2024 Q2
+24.9% Combined book
+25.3% SPY
That quarter: book +2.6%, SPY +2.4%
2026 Q1, since 2024 Q2
+19.6% Combined book
+19.5% SPY
That quarter: book −4.2%, SPY −4.6%
2026 Q2, since 2024 Q2
+33.3% Combined book
+37.2% SPY
That quarter: book +11.5%, SPY +14.8%
Quarter by quarter
| Quarter | Each manager once | By dollars | SPY | Book − SPY | Managers |
|---|---|---|---|---|---|
| 2026 Q2 | +14.5% | +11.5% | +14.8% | −3.4 pts | 133 |
| 2026 Q1 | −4.4% | −4.2% | −4.6% | +0.4 pts | 136 |
| 2025 Q4 | +2.1% | +2.6% | +2.4% | +0.2 pts | 136 |
| 2025 Q3 | +9.1% | +6.3% | +7.8% | −1.5 pts | 136 |
| 2025 Q2 | +11.6% | +8.0% | +10.5% | −2.4 pts | 136 |
| 2025 Q1 | −3.8% | −2.0% | −4.6% | +2.6 pts | 136 |
| 2024 Q4 | +2.6% | +1.1% | +2.1% | −1.0 pts | 134 |
| 2024 Q3 | +7.5% | +6.9% | +5.4% | +1.5 pts | 133 |
All 2,486 names
Download CSVShowing 300 of 356 matching names. The CSV has every name.
| Ticker | Company | Sector | Held by | Weight, $ | Net bought | Bought / sold | Opened / closed |
|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group Inc. | Health Care | 29 −3 | 0.70% | −$33M | 7 / 14 | 3 / 6 |
| DHR | Danaher Corporation | Health Care | 18 +2 | 0.08% | −$63M | 7 / 8 | 4 / 2 |
| TMO | Thermo Fisher Scientific Inc. | Health Care | 15 −2 | 0.20% | −$312M | 3 / 9 | 0 / 2 |
| JNJ | Johnson & Johnson | Health Care | 15 | 0.06% | −$265M | 0 / 3 | 0 / 0 |
| ELV | Elevance Health Inc. | Health Care | 14 +1 | 0.49% | +$177M | 3 / 2 | 1 / 0 |
| LLY | Eli Lilly & Co. | Health Care | 14 −2 | 0.30% | +$341M | 6 / 5 | 0 / 2 |
| CVS | Cvs Health Corp. | Health Care | 13 | 0.65% | +$303M | 3 / 3 | 0 / 0 |
| PFE | Pfizer Inc. | Health Care | 13 +1 | 0.04% | −$184M | 4 / 3 | 1 / 0 |
| BMY | Bristol-Myers Squibb Co. | Health Care | 12 −1 | 0.13% | −$347M | 2 / 6 | 1 / 2 |
| MRK | Merck & Co. Inc. | Health Care | 12 −1 | 0.06% | +$136M | 2 / 3 | 0 / 1 |
| ABT | Abbott Labs | Health Care | 11 +1 | 0.15% | −$19M | 3 / 3 | 2 / 1 |
| ABBV | Abbvie Inc. | Health Care | 11 −3 | 0.01% | −$102M | 1 / 8 | 0 / 3 |
| CI | The Cigna Group | Health Care | 10 | 0.50% | −$74M | 1 / 1 | 0 / 0 |
| HCA | Hca Healthcare Inc. | Health Care | 10 −1 | 0.49% | +$2M | 3 / 4 | 1 / 2 |
| MDT | Medtronic PLC | Health Care | 10 +1 | 0.19% | −$10M | 2 / 3 | 1 / 0 |
| ZBH | Zimmer Biomet Holdings, Inc. | Health Care | 10 | 0.18% | +$60M | 1 / 2 | 0 / 0 |
| BAX | Baxter International, Inc. | Health Care | 9 | 0.26% | +$173M | 3 / 3 | 0 / 0 |
| ZTS | Zoetis Inc. | Health Care | 9 | 0.20% | +$545M | 2 / 2 | 0 / 0 |
| BDX | Becton Dickinson & Co. | Health Care | 9 +1 | 0.16% | +$893M | 4 / 4 | 2 / 1 |
| GEHC | Ge Healthcare Technologies, Inc. | Health Care | 9 −2 | 0.15% | −$592M | 2 / 3 | 0 / 2 |
| BSX | Boston Scientific Corp. | Health Care | 8 | 0.07% | +$96M | 2 / 4 | 1 / 1 |
| TEVA | Teva Pharmaceutical Inds Ltd | Health Care | 8 −1 | 0.05% | +$261M | 7 / 3 | 1 / 2 |
| ILMN | Illumina Inc. | Health Care | 8 −1 | 0.04% | −$101M | 3 / 6 | 0 / 1 |
| AMGN | Amgen Inc. | Health Care | 8 −1 | <0.01% | −$3M | 0 / 4 | 0 / 1 |
| GSK | Gsk PLC | Health Care | 7 +1 | 0.24% | +$402M | 2 / 2 | 1 / 0 |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | 7 +2 | 0.12% | +$148M | 3 / 0 | 2 / 0 |
| NTRA | Natera Inc. | Health Care | 7 | 0.11% | +$20M | 2 / 3 | 0 / 0 |
| WST | West Pharmaceutical Svsc Inc. | Health Care | 7 | 0.06% | +$298M | 2 / 2 | 1 / 1 |
| ICLR | Icon PLC | Health Care | 7 −1 | 0.05% | +$67M | 4 / 3 | 1 / 2 |
| THC | Tenet Healthcare Corp. | Health Care | 7 | 0.04% | +$93M | 4 / 3 | 0 / 0 |
| DGX | Quest Diagnostics Inc. | Health Care | 7 | 0.03% | −$34M | 1 / 3 | 0 / 0 |
| NVO | Novo-Nordisk A S | Health Care | 7 −1 | 0.02% | −$381M | 1 / 2 | 0 / 1 |
| INSM | Insmed Inc. | Health Care | 7 | 0.02% | +$15M | 2 / 4 | 1 / 1 |
| HUM | Humana, Inc. | Health Care | 6 −2 | 0.36% | +$129M | 2 / 3 | 0 / 2 |
| SNY | Sanofi SA | Health Care | 6 | 0.31% | −$120M | 3 / 1 | 1 / 1 |
| SYK | Stryker Corporation | Health Care | 6 | 0.18% | −$190M | 0 / 3 | 0 / 0 |
| IDXX | Idexx Labs Inc. | Health Care | 6 +2 | 0.16% | +$195M | 2 / 1 | 2 / 0 |
| NVS | Novartis AG | Health Care | 6 | 0.10% | −$45M | 0 / 1 | 0 / 0 |
| SOLV | Solventum Corporation | Health Care | 6 | 0.08% | −$27M | 0 / 2 | 0 / 0 |
| MCK | Mckesson Corp. | Health Care | 6 +1 | 0.05% | −$263M | 2 / 4 | 2 / 1 |
| TECH | Bio Techne Corp. | Health Care | 6 +1 | 0.03% | +$4M | 3 / 2 | 1 / 0 |
| MEDP | Medpace Hldgs Inc. | Health Care | 6 +1 | 0.02% | +$79M | 4 / 0 | 1 / 0 |
| CAH | Cardinal Health Inc. | Health Care | 6 +1 | <0.01% | +$35M | 1 / 2 | 1 / 0 |
| IQV | Iqvia Hldgs Inc. | Health Care | 5 −1 | 0.22% | +$7M | 1 / 2 | 0 / 1 |
| AVTR | Avantor, Inc. | Health Care | 5 −1 | 0.13% | −$73M | 1 / 4 | 0 / 1 |
| CNC | Centene Corp. Del | Health Care | 5 | 0.11% | −$332M | 1 / 3 | 1 / 1 |
| VTRS | Viatris Inc. | Health Care | 5 | 0.05% | +$15M | 0 / 1 | 0 / 0 |
| VEEV | Veeva Sys Inc. | Health Care | 5 | 0.05% | +$463M | 1 / 4 | 0 / 0 |
| NBIX | Neurocrine Biosciences, Inc. | Health Care | 5 +1 | 0.05% | +$269M | 3 / 1 | 1 / 0 |
| RPRX | Royalty Pharma PLC | Health Care | 5 +1 | 0.03% | −$40M | 2 / 1 | 1 / 0 |
| ISRG | Intuitive Surgical Inc. | Health Care | 5 −2 | 0.03% | −$175M | 0 / 4 | 0 / 2 |
| COR | Cencora Inc. | Health Care | 5 +2 | 0.02% | +$308M | 2 / 1 | 2 / 0 |
| ACHC | Acadia Healthcare Company In | Health Care | 5 | 0.02% | +$152M | 4 / 2 | 1 / 1 |
| OSCR | Oscar Health Inc. | Health Care | 5 | 0.02% | −$77M | 1 / 3 | 1 / 1 |
| BIIB | Biogen Inc. | Health Care | 5 −1 | 0.01% | +$13M | 3 / 1 | 0 / 1 |
| BNTX | Biontech Se | Health Care | 5 | <0.01% | −$7M | 1 / 3 | 0 / 0 |
| ALKS | Alkermes PLC | Health Care | 5 +1 | <0.01% | +$41M | 1 / 3 | 1 / 0 |
| VRTX | Vertex Pharmaceuticals | Health Care | 5 +1 | <0.01% | +$13M | 1 / 2 | 1 / 0 |
| ALGN | Align Technology Inc. | Health Care | 5 −1 | <0.01% | −$120K | 1 / 3 | 0 / 1 |
| GILD | Gilead Sciences, Inc. | Health Care | 4 | 0.28% | −$42M | 2 / 2 | 1 / 1 |
| BMRN | Biomarin Pharmaceutical, Inc. | Health Care | 4 | 0.16% | +$30M | 0 / 1 | 0 / 0 |
| WAT | Waters Corp. | Health Care | 4 +1 | 0.13% | +$23M | 2 / 0 | 1 / 0 |
| UHS | Universal Hlth Svcs Inc. | Health Care | 4 +1 | 0.08% | +$14M | 1 / 0 | 1 / 0 |
| MTD | Mettler Toledo International | Health Care | 4 | 0.08% | −$450K | 1 / 0 | 0 / 0 |
| BBIO | Bridgebio Pharma Inc. | Health Care | 4 +2 | 0.07% | −$35M | 3 / 1 | 2 / 0 |
| ALNY | Alnylam Pharmaceuticals, Inc. | Health Care | 4 +1 | 0.07% | −$50M | 1 / 2 | 1 / 0 |
| BIO | Bio Rad Labs Inc. | Health Care | 4 | 0.05% | +$304M | 3 / 0 | 0 / 0 |
| A | Agilent Technologies Inc. | Health Care | 4 | 0.04% | −$15M | 0 / 1 | 0 / 0 |
| NVST | Envista Holdings Corporation | Health Care | 4 | 0.03% | +$13M | 1 / 1 | 0 / 0 |
| HSIC | Henry Schein, Inc. | Health Care | 4 −1 | 0.01% | −$26M | 0 / 2 | 0 / 1 |
| NAMS | Newamsterdam Pharma Company | Health Care | 4 −1 | 0.01% | +$2M | 2 / 2 | 0 / 1 |
| BHVN | Biohaven Ltd | Health Care | 4 | <0.01% | +$7M | 1 / 2 | 0 / 0 |
| IONS | Ionis Pharmaceuticals Inc. | Health Care | 4 +1 | <0.01% | −$7M | 1 / 1 | 1 / 0 |
| HOLX | Hologic, Inc. | Health Care | 4 | <0.01% | +$27M | 2 / 1 | 0 / 0 |
| UTHR | United Therapeutics Corp. | Health Care | 4 +1 | <0.01% | −$26M | 1 / 2 | 1 / 0 |
| SNDX | Syndax Pharmaceuticals Inc. | Health Care | 4 | <0.01% | −$7M | 1 / 1 | 0 / 0 |
| EW | Edwards Lifesciences Corp. | Health Care | 4 −4 | <0.01% | −$65M | 0 / 5 | 0 / 4 |
| PGNY | Progyny Inc. | Health Care | 4 +1 | <0.01% | +$896K | 2 / 0 | 1 / 0 |
| INCY | Incyte Corp. | Health Care | 3 −1 | 0.07% | +$7M | 1 / 1 | 0 / 1 |
| EXEL | Exelixis Inc. | Health Care | 3 | 0.06% | −$48M | 1 / 1 | 0 / 0 |
| ALC | Alcon AG | Health Care | 3 +2 | 0.06% | +$298M | 3 / 0 | 2 / 0 |
| ROIV | Roivant Sciences Ltd | Health Care | 3 | 0.04% | −$16M | 0 / 0 | 0 / 0 |
| RVMD | Revolution Medicines Inc. | Health Care | 3 | 0.04% | +$3M | 1 / 1 | 0 / 0 |
| FMS | Fresenius Medical Care AG | Health Care | 3 +1 | 0.04% | +$3M | 1 / 0 | 1 / 0 |
| BHC | Bausch Health Companies Inc. | Health Care | 3 −1 | 0.03% | −$74K | 0 / 1 | 0 / 1 |
| BEAM | Beam Therapeutics Inc. | Health Care | 3 | 0.03% | +$74M | 3 / 1 | 1 / 1 |
| CRL | Charles Riv Labs Intl Inc. | Health Care | 3 −2 | 0.02% | −$185M | 0 / 4 | 0 / 2 |
| INSP | Inspire Med Sys Inc. | Health Care | 3 | 0.02% | +$81M | 3 / 0 | 0 / 0 |
| XRAY | Dentsply Sirona Inc. | Health Care | 3 +1 | 0.02% | +$12M | 2 / 0 | 1 / 0 |
| PBH | Prestige Consmr Healthcare I | Health Care | 3 | 0.02% | −$22M | 0 / 2 | 0 / 0 |
| ITGR | Integer Hldgs Corp. | Health Care | 3 +1 | 0.01% | +$21M | 2 / 0 | 1 / 0 |
| LH | Labcorp Holdings Inc. | Health Care | 3 | <0.01% | −$27M | 0 / 3 | 0 / 0 |
| OGN | Organon & Company | Health Care | 3 +1 | <0.01% | +$22M | 2 / 0 | 1 / 0 |
| HQY | Healthequity Inc. | Health Care | 3 +1 | <0.01% | +$44M | 2 / 0 | 1 / 0 |
| SHC | Sotera Health Co. | Health Care | 3 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| NVAX | Novavax Inc. | Health Care | 3 +1 | <0.01% | +$24M | 1 / 0 | 1 / 0 |
| CDNA | Caredx Inc. | Health Care | 3 | <0.01% | −$6M | 0 / 1 | 0 / 0 |
| BTI | British Amern Tob PLC | Health Care | 3 | <0.01% | +$904K | 0 / 0 | 0 / 0 |
| JAZZ | Jazz Pharmaceuticals PLC | Health Care | 3 | <0.01% | −$11M | 1 / 2 | 0 / 0 |
| DXCM | Dexcom Inc. | Health Care | 3 | <0.01% | −$9M | 0 / 1 | 0 / 0 |
| BBNX | Beta Bionics Inc. IPO or spin-off | Health Care | 3 +3 | <0.01% | +$41M | 3 / 0 | 3 / 0 |
| ASND | Ascendis Pharma A/S | Health Care | 3 | <0.01% | −$30M | 1 / 3 | 1 / 1 |
| DNA | Ginkgo Bioworks Holdings Inc. | Health Care | 3 | <0.01% | −$29K | 0 / 0 | 0 / 0 |
| EWTX | Edgewise Therapeutics Inc. | Health Care | 3 −1 | <0.01% | −$19M | 0 / 3 | 0 / 1 |
| IMVT | Immunovant Inc. | Health Care | 3 | <0.01% | −$4M | 1 / 1 | 0 / 0 |
| BKD | Brookdale Sr Living Inc. | Health Care | 3 | <0.01% | +$1M | 2 / 1 | 0 / 0 |
| XENE | Xenon Pharmaceuticals Inc. | Health Care | 3 | <0.01% | −$8M | 0 / 1 | 0 / 0 |
| GKOS | Glaukos Corp. | Health Care | 3 | <0.01% | −$3M | 0 / 1 | 0 / 0 |
| AXSM | Axsome Therapeutics Inc. | Health Care | 3 | <0.01% | −$13M | 0 / 1 | 0 / 0 |
| NUVB | Nuvation Bio Inc. | Health Care | 3 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| URGN | Urogen Pharma Ltd | Health Care | 3 −1 | <0.01% | −$2M | 1 / 1 | 0 / 1 |
| LXEO | Lexeo Therapeutics Inc. | Health Care | 3 | <0.01% | −$3M | 1 / 2 | 1 / 1 |
| STOK | Stoke Therapeutics Inc. | Health Care | 3 | <0.01% | +$4M | 2 / 0 | 0 / 0 |
| DYN | Dyne Therapeutics Inc. | Health Care | 3 | <0.01% | −$1M | 1 / 3 | 1 / 1 |
| BCYC | Bicycle Therapeutics Plc-Adr | Health Care | 3 | <0.01% | −$340K | 0 / 1 | 0 / 0 |
| Compugen | Compugen Ltd | Health Care | 3 +1 | <0.01% | +$1M | 1 / 1 | 1 / 0 |
| DVA | Davita Inc. | Health Care | 2 −1 | 0.40% | −$181M | 1 / 1 | 0 / 1 |
| ELAN | Elanco Animal Health, Inc. | Health Care | 2 | 0.07% | −$3M | 0 / 0 | 0 / 0 |
| MDGL | Madrigal Pharmaceuticals Inc. | Health Care | 2 | 0.05% | +$19M | 1 / 0 | 0 / 0 |
| LNTH | Lantheus Hldgs Inc. | Health Care | 2 | 0.04% | +$69M | 1 / 0 | 0 / 0 |
| MOH | Molina Healthcare Inc. | Health Care | 2 +1 | 0.04% | +$366M | 2 / 0 | 1 / 0 |
| CRSP | Crispr Therapeutics AG | Health Care | 2 | 0.03% | +$41M | 1 / 0 | 0 / 0 |
| PTGX | Protagonist Therapeutics Inc. | Health Care | 2 | 0.02% | +$9M | 0 / 0 | 0 / 0 |
| ADPT | Adaptive Biotechnologies Cor | Health Care | 2 | 0.02% | −$13M | 0 / 1 | 0 / 0 |
| WGS | Genedx Holdings Corp. | Health Care | 2 | 0.02% | +$10M | 1 / 0 | 0 / 0 |
| TWST | Twist Bioscience Corp. | Health Care | 2 | 0.02% | +$25M | 1 / 0 | 0 / 0 |
| Masimo | Masimo Corp. | Health Care | 2 −1 | 0.02% | +$123M | 1 / 2 | 1 / 2 |
| SDGR | Schrodinger Inc. | Health Care | 2 | 0.01% | +$2M | 0 / 0 | 0 / 0 |
| AGIO | Agios Pharmaceuticals Inc. | Health Care | 2 +1 | 0.01% | +$9M | 1 / 0 | 1 / 0 |
| VCYT | Veracyte Inc. | Health Care | 2 | 0.01% | −$8M | 0 / 1 | 0 / 0 |
| MMSI | Merit Med Sys Inc. | Health Care | 2 +1 | 0.01% | +$135M | 1 / 0 | 1 / 0 |
| INDV | Indivior PLC | Health Care | 2 | <0.01% | +$24M | 2 / 0 | 0 / 0 |
| Perrigo | Perrigo Company PLC | Health Care | 2 | <0.01% | +$20M | 2 / 0 | 0 / 0 |
| LQDA | Liquidia Corporation | Health Care | 2 | <0.01% | +$19M | 2 / 0 | 0 / 0 |
| WAY | Waystar Hldg Corp. | Health Care | 2 | <0.01% | +$27M | 2 / 0 | 0 / 0 |
| COO | Cooper Cos Inc. | Health Care | 2 −2 | <0.01% | −$191M | 0 / 2 | 0 / 2 |
| DOCS | Doximity Inc. | Health Care | 2 | <0.01% | −$133M | 2 / 1 | 1 / 1 |
| FTRE | Fortrea Hldgs Inc. | Health Care | 2 | <0.01% | −$9M | 1 / 1 | 0 / 0 |
| CNTA | Centessa Pharmaceuticals PLC | Health Care | 2 −1 | <0.01% | +$2M | 1 / 2 | 0 / 1 |
| EHC | Encompass Health Corp. | Health Care | 2 | <0.01% | +$15M | 1 / 1 | 0 / 0 |
| NEOG | Neogen Corp. | Health Care | 2 | <0.01% | −$8M | 0 / 1 | 0 / 0 |
| FOLD | Amicus Therapeutics Inc. | Health Care | 2 | <0.01% | −$3M | 0 / 1 | 0 / 0 |
| BLCO | Bausch Plus Lomb Corp. | Health Care | 2 | <0.01% | −$9M | 1 / 1 | 1 / 1 |
| TVTX | Travere Therapeutics Inc. | Health Care | 2 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| ACAD | Acadia Pharmaceuticals Inc. | Health Care | 2 +1 | <0.01% | +$1M | 1 / 1 | 1 / 0 |
| PCVX | Vaxcyte Inc. | Health Care | 2 −2 | <0.01% | −$6M | 1 / 3 | 1 / 3 |
| PHG | Koninklijke Philips NV | Health Care | 2 | <0.01% | −$838K | 1 / 0 | 0 / 0 |
| BFLY | Butterfly Network Inc. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| RDNT | Radnet Inc. | Health Care | 2 | <0.01% | +$32M | 1 / 1 | 0 / 0 |
| ORIC | Oric Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$6M | 2 / 1 | 1 / 1 |
| AVAH | Aveanna Healthcare Hldgs Inc. | Health Care | 2 | <0.01% | +$798K | 1 / 0 | 0 / 0 |
| RCKT | Rocket Pharmaceuticals Inc. | Health Care | 2 −2 | <0.01% | −$8M | 0 / 2 | 0 / 2 |
| EMBC | Embecta Corp. | Health Care | 2 | <0.01% | −$149K | 0 / 0 | 0 / 0 |
| RGEN | Repligen Corp. | Health Care | 2 | <0.01% | +$4M | 1 / 1 | 0 / 0 |
| NVCR | Novocure Ltd | Health Care | 2 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| CGON | Cg Oncology Inc. | Health Care | 2 +1 | <0.01% | +$1M | 1 / 1 | 1 / 0 |
| TRVI | Trevi Therapeutics Inc. | Health Care | 2 | <0.01% | −$17M | 0 / 2 | 0 / 0 |
| SRTA | Blade Air Mobility Inc. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| GRFS | Grifols S A | Health Care | 2 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| CYTK | Cytokinetics Inc. | Health Care | 2 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| ANAB | Anaptysbio Inc. | Health Care | 2 +1 | <0.01% | +$8M | 2 / 0 | 1 / 0 |
| CAPR | Capricor Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| ENTA | Enanta Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| SUPN | Supernus Pharmaceuticals Inc. | Health Care | 2 +1 | <0.01% | +$14M | 1 / 0 | 1 / 0 |
| NRIX | Nurix Therapeutics Inc. | Health Care | 2 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| ALVO | Alvotech SA | Health Care | 2 | <0.01% | −$553K | 0 / 0 | 0 / 0 |
| IDYA | Ideaya Biosciences Inc. | Health Care | 2 | <0.01% | −$10M | 1 / 1 | 0 / 0 |
| ARVN | Arvinas Inc. | Health Care | 2 | <0.01% | −$4M | 1 / 1 | 0 / 0 |
| LKFT | Galapagos NV | Health Care | 2 | <0.01% | +$85K | 0 / 0 | 0 / 0 |
| RARE | Ultragenyx Pharmaceutical In | Health Care | 2 −1 | <0.01% | −$3M | 0 / 2 | 0 / 1 |
| ENOV | Enovis Corporation | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| AXGN | Axogen Inc. | Health Care | 2 | <0.01% | −$3M | 0 / 1 | 0 / 0 |
| VKTX | Viking Therapeutics Inc. | Health Care | 2 | <0.01% | +$404K | 0 / 0 | 0 / 0 |
| IOVA | Iovance Biotherapeutics Inc. | Health Care | 2 | <0.01% | +$565K | 1 / 0 | 0 / 0 |
| PRME | Prime Medicine Inc. | Health Care | 2 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| CMPS | Compass Pathways PLC | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| IVVD | Invivyd Inc. | Health Care | 2 | <0.01% | −$489K | 0 / 1 | 0 / 0 |
| PVLA | Palvella Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$4M | 1 / 1 | 1 / 0 |
| BRKR | Bruker Corp. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| LRMR | Larimar Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| TMDX | Transmedics Group Inc. | Health Care | 2 +1 | <0.01% | −$8M | 2 / 1 | 2 / 1 |
| MIRM | Mirum Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$28M | 0 / 1 | 0 / 0 |
| QURE | Uniqure NV | Health Care | 2 +1 | <0.01% | +$1M | 2 / 0 | 1 / 0 |
| VNDA | Vanda Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| BWAY | Brainsway Ltd | Health Care | 2 | <0.01% | −$227K | 1 / 1 | 0 / 0 |
| TSHA | Taysha Gene Therapies Inc. | Health Care | 2 | <0.01% | +$845K | 1 / 0 | 0 / 0 |
| PEPG | Pepgen Inc. | Health Care | 2 | <0.01% | +$436K | 1 / 0 | 0 / 0 |
| LIVN | Livanova PLC | Health Care | 2 +1 | <0.01% | +$2M | 2 / 0 | 1 / 0 |
| ALLO | Allogene Therapeutics Inc. | Health Care | 2 | <0.01% | +$204K | 1 / 0 | 0 / 0 |
| DCGO | Docgo Inc. | Health Care | 2 | <0.01% | +$908K | 1 / 0 | 0 / 0 |
| PRVA | Privia Health Group Inc. | Health Care | 1 −1 | 0.02% | −$16M | 0 / 1 | 0 / 1 |
| HIMS | Hims & Hers Health Inc. | Health Care | 1 | 0.02% | −$13M | 0 / 1 | 0 / 0 |
| RXRX | Recursion Pharmaceuticals Inc. | Health Care | 1 | 0.01% | +$13M | 1 / 0 | 0 / 0 |
| CRNX | Crinetics Pharmaceuticals In | Health Care | 1 −1 | 0.01% | +$14M | 1 / 1 | 0 / 1 |
| ARGX | Argenx Se | Health Care | 1 | <0.01% | −$17M | 0 / 1 | 0 / 0 |
| OPCH | Option Care Health Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$123M | 1 / 0 | 1 / 0 |
| SGRY | Surgery Partners Inc. | Health Care | 1 −2 | <0.01% | +$33M | 1 / 2 | 0 / 2 |
| HROW | Harrow Health Inc. | Health Care | 1 | <0.01% | −$931K | 0 / 0 | 0 / 0 |
| ALHC | Alignment Healthcare Inc. | Health Care | 1 | <0.01% | −$19M | 0 / 1 | 0 / 0 |
| WVE | Wave Life Sciences Ltd | Health Care | 1 −1 | <0.01% | −$683K | 0 / 1 | 0 / 1 |
| ZLAB | Zai Lab Ltd | Health Care | 1 | <0.01% | −$3M | 0 / 0 | 0 / 0 |
| GH | Guardant Health Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 0 | 0 / 0 |
| PHVS | Pharvaris N V | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| Catalyst Pharmaceutic… | Catalyst Pharmaceuticals Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$52M | 1 / 0 | 1 / 0 |
| ETON | Eton Pharmaceuticals Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| MYGN | Myriad Genetics Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| SNWV | Sanuwave Health Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$34M | 1 / 0 | 1 / 0 |
| DNTH | Dianthus Therapeutics Inc. | Health Care | 1 | <0.01% | −$21M | 0 / 1 | 0 / 0 |
| SION | Sionna Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$31M | 1 / 0 | 1 / 0 |
| ESTA | Establishment Labs Hldgs Inc. | Health Care | 1 | <0.01% | −$249K | 0 / 0 | 0 / 0 |
| USNA | Usana Health Sciences Inc. | Health Care | 1 | <0.01% | +$219K | 0 / 0 | 0 / 0 |
| CERS | Cerus Corp. | Health Care | 1 | <0.01% | −$222K | 0 / 0 | 0 / 0 |
| ABSI | Absci Corp. | Health Care | 1 | <0.01% | +$7M | 1 / 0 | 0 / 0 |
| RYTM | Rhythm Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$530K | 0 / 0 | 0 / 0 |
| PGEN | Precigen Inc. | Health Care | 1 | <0.01% | −$758K | 0 / 0 | 0 / 0 |
| LFCR | Lifecore Biomedical Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PSNL | Personalis Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| INBX | Inhibrx Biosciences Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| STXS | Stereotaxis Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ARCT | Arcturus Therapeutics Holdings | Health Care | 1 | <0.01% | +$790K | 0 / 0 | 0 / 0 |
| TGTX | Tg Therapeutics Inc. | Health Care | 1 | <0.01% | −$68M | 0 / 1 | 0 / 0 |
| PRTA | Prothena Corp. PLC | Health Care | 1 | <0.01% | −$968K | 0 / 0 | 0 / 0 |
| ATRC | Atricure Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| Enhabit | Enhabit Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| SNN | Smith & Nephew PLC | Health Care | 1 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| TECX | Tectonic Therapeutic Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| CRMD | Cormedix Inc. | Health Care | 1 | <0.01% | −$3M | 0 / 1 | 0 / 0 |
| HSTM | Healthstream Inc. | Health Care | 1 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| EOLS | Evolus Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| Bausch Lomb | Bausch Lomb Corp. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| OCUL | Ocular Therapeutix Inc. | Health Care | 1 | <0.01% | −$20M | 0 / 1 | 0 / 0 |
| PNTG | Pennant Group Inc. | Health Care | 1 | <0.01% | +$415K | 0 / 0 | 0 / 0 |
| COYA | Coya Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| AORT | Artivion Inc. | Health Care | 1 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| NUVL | Nuvalent Inc. | Health Care | 1 −1 | <0.01% | −$4M | 0 / 1 | 0 / 1 |
| TYRA | Tyra Biosciences Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| AHCO | Adapthealth Corp. | Health Care | 1 | <0.01% | −$168K | 0 / 0 | 0 / 0 |
| VYGR | Voyager Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| Kalvista Pharmaceutic… | Kalvista Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$685K | 0 / 1 | 0 / 0 |
| ATEC | Alphatec Hldgs Inc. | Health Care | 1 | <0.01% | +$527K | 1 / 0 | 0 / 0 |
| CON | Concentra Group Holdings Par | Health Care | 1 | <0.01% | +$437K | 1 / 0 | 0 / 0 |
| LFST | Lifestance Health Group Inc. | Health Care | 1 −1 | <0.01% | −$62M | 1 / 1 | 0 / 1 |
| LZAGY | Lonza Group Adr | Health Care | 1 | <0.01% | −$173K | 0 / 0 | 0 / 0 |
| Select Med | Select Med Hldgs Corp. | Health Care | 1 | <0.01% | +$247K | 0 / 0 | 0 / 0 |
| TNGX | Tango Therapeutics Inc. | Health Care | 1 | <0.01% | +$837K | 1 / 0 | 0 / 0 |
| DMAC | Diamedica Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| GMED | Globus Med Inc. | Health Care | 1 | <0.01% | +$6M | 1 / 0 | 0 / 0 |
| COLL | Collegium Pharmaceutical Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ANIK | Anika Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$6M | 1 / 0 | 1 / 0 |
| AZTA | Azenta Inc. | Health Care | 1 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| TNDM | Tandem Diabetes Care Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| GUTS | Fractyl Health Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| XOMA | Xoma Corp. Del | Health Care | 1 | <0.01% | +$61K | 0 / 0 | 0 / 0 |
| PHAT | Phathom Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| INFU | Infusystem Hldgs Inc. | Health Care | 1 | <0.01% | +$65K | 0 / 0 | 0 / 0 |
| MLYS | Mineralys Therapeutics Inc. | Health Care | 1 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| RCUS | Arcus Biosciences Inc. | Health Care | 1 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| CATX | Perspective Therapeutics Inc. | Health Care | 1 −1 | <0.01% | −$1M | 0 / 2 | 0 / 1 |
| CNTX | Context Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| SIBN | Si-Bone Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| IRON | Disc Medicine Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| BCRX | Biocryst Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$816K | 0 / 1 | 0 / 0 |
| ORKA | Oruka Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RCEL | Avita Medical Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| ANGO | Angiodynamics Inc. | Health Care | 1 | <0.01% | −$305K | 0 / 1 | 0 / 0 |
| HALO | Halozyme Therapeutics | Health Care | 1 | <0.01% | −$14K | 0 / 0 | 0 / 0 |
| INGN | Inogen Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| ZNTL | Zentalis Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$346K | 1 / 0 | 0 / 0 |
| PODD | Insulet Corp. | Health Care | 1 | <0.01% | −$131K | 0 / 0 | 0 / 0 |
| CERT | Certara Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| VMD | Viemed Healthcare Inc. | Health Care | 1 | <0.01% | +$703K | 1 / 0 | 0 / 0 |
| KURA | Kura Oncology Inc. | Health Care | 1 | <0.01% | +$99K | 0 / 0 | 0 / 0 |
| TALK | Talkspace Inc. | Health Care | 1 −1 | <0.01% | −$7M | 1 / 1 | 0 / 1 |
| BCAX | Bicara Therapeutics Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| PEN | Penumbra Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| MRNA | Moderna Inc. | Health Care | 1 | <0.01% | −$3M | 1 / 1 | 1 / 1 |
| ARAY | Accuray Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| IART | Integra Lifesciences Hldgs | Health Care | 1 | <0.01% | −$770K | 0 / 1 | 0 / 0 |
| PRQR | Proqr Therapeutics N V | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| Inmode | Inmode Ltd | Health Care | 1 | <0.01% | +$193K | 1 / 0 | 0 / 0 |
| SYRE | Spyre Therapeutics Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| RDY | Dr Reddy's Laboratories Ltd | Health Care | 1 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| FTLF | Fitlife Brands Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| MBX | Mbx Biosciences Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| CVRX | Cvrx Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| TELA | Tela Bio Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DNLI | Denali Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| IRD | Opus Genetics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| IBIO | Ibio Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RZLT | Rezolute Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ALDX | Aldeyra Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| SPRY | Ars Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$82K | 1 / 0 | 0 / 0 |
| ACRS | Aclaris Therapeutics Inc. | Health Care | 1 | <0.01% | +$315K | 1 / 0 | 0 / 0 |
| VCEL | Vericel Corp. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| Nano-X Imaging | Nano-X Imaging Ltd | Health Care | 1 | <0.01% | −$355K | 0 / 1 | 0 / 0 |
| ALEC | Alector Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| FHTX | Foghorn Therapeutics Inc. | Health Care | 1 | <0.01% | +$431K | 1 / 0 | 0 / 0 |
| GANX | Gain Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| GPCR | Structure Therapeutics Inc. | Health Care | 1 | <0.01% | +$407K | 1 / 0 | 0 / 0 |
| PYXS | Pyxis Oncology Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
How the numbers work
Same managers in both quarters
Changes compare only managers with a 13F in both 2024 Q4 and 2025 Q1: 136 this time.
Buying versus price
Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.
Who counts as a buyer or a seller
A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.
IPOs, spin-offs and mergers
A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.
Each manager once, or by dollars
By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.
Sectors
GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.
The combined book against SPY
Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.
What a 13F leaves out
Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.